-
Mashup Score: 12Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies | Keystone Symposia - 11 day(s) ago
Join us at the Keystone Symposia on Neurodegeneration: Linking Cellular Pathways to Therapeutic Strategies, June 2025, in Whistler, with field leaders!
Source: www.keystonesymposia.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 17
Nature Genetics – Base editing of the pathogenic trinucleotide repeat expansions underlying Huntington’s disease and Friedreich’s ataxia introduces repeat interruptions that reduce…
Source: www.nature.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 10Advancing neurogenetics in Africa: past achievements, current developments and shaping the future - 14 day(s) ago
Nature Reviews Neurology – Genetic studies in Africa can provide a unique window into hereditary neurological diseases (HNDs). This Review highlights the benefits and challenges of conducting…
Source: www.nature.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 287
Nature Reviews Neurology – In this Review, Taddei and Duff consider the concepts of synapse vulnerability and resilience, and how an understanding of the mechanisms that underlie these states could…
Source: www.nature.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 9
Nature – Following spinal cord injury, gamified physical therapy that incorporates closed-loop vagus nerve stimulation can aid restoration of arm and hand function.
Source: www.nature.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 14Choroid plexus free‐water correlates with glymphatic function in Alzheimer's disease - 17 day(s) ago
INTRODUCTION Free-water imaging of the choroid plexus (CP) may improve the evaluation of Alzheimer’s disease (AD). METHODS Our study investigated the role of free-water fraction (FWf) of CP in AD …
Categories: General Medicine News, NeurologyTweet
-
Mashup Score: 15TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease - 18 day(s) ago
INTRODUCTION The phase 3, open-label TRAILBLAZER-ALZ 4 study compared the effect of donanemab versus aducanumab on amyloid plaque (AP) clearance in participants with early symptomatic Alzheimer’s di…
Categories: General Medicine News, NeurologyTweet
-
Mashup Score: 22Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease - 19 day(s) ago
Acta Neuropathologica – Trisomy of chromosome 21, the cause of Down syndrome (DS), is the most commonly occurring genetic cause of Alzheimer’s disease (AD). Here, we compare the frontal…
Source: link.springer.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5Peripheral Mononuclear Cell Mitochondrial Function Associates with T‐Cell Cytokines in Parkinson's Disease - 19 day(s) ago
Background Parkinson’s disease (PD) is the most common neurodegenerative movement disorder and one of the world’s fastest-growing neurological diseases. Although the exact causes of PD are unknown, …
Categories: General Medicine News, NeurologyTweet
-
Mashup Score: 7AI aces diagnosis of chronic ataxias - 23 day(s) ago
Nature Reviews Neurology – A bespoke virtual assistant based on artificial intelligence has outperformed neurologists in the diagnosis of chronic ataxias in a recent study.
Source: www.nature.comCategories: General Medicine News, NeurologyTweet
Register now for Livestream and On Demand Access to @KeystoneSymp #Neurodegeneration : Linking #CellularPathways to Therapeutic Strategies, this June to explore emerging research! https://t.co/nBGJkxL46y #KSNeuroDegen25 https://t.co/O7UyoFMFZz